Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects
- PMID: 11331648
- DOI: 10.1093/humrep/16.5.972
Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects
Abstract
Numerous reports have recently focused on various aspects of adverse trends in male reproductive health, such as the rising incidence of testicular cancer; low and probably declining semen quality; high and possibly increasing frequencies of undescended testis and hypospadias; and an apparently growing demand for assisted reproduction. Due to specialization in medicine and different ages at presentation of symptoms, reproductive problems used to be analysed separately by various professional groups, e.g. paediatric endocrinologists, urologists, andrologists and oncologists. This article summarizes existing evidence supporting a new concept that poor semen quality, testis cancer, undescended testis and hypospadias are symptoms of one underlying entity, the testicular dysgenesis syndrome (TDS), which may be increasingly common due to adverse environmental influences. Experimental and epidemiological studies suggest that TDS is a result of disruption of embryonal programming and gonadal development during fetal life. Therefore, we recommend that future epidemiological studies on trends in male reproductive health should not focus on one symptom only, but be more comprehensive and take all aspects of TDS into account. Otherwise, important biological information may be lost.
Similar articles
-
Testicular dysgenesis syndrome.Horm Res. 2003;60 Suppl 3:49. doi: 10.1159/000074499. Horm Res. 2003. PMID: 14671395
-
Ethnic differences in occurrence of TDS-- genetics and/or environment?Int J Androl. 2006 Feb;29(1):291-7; discussion 304-6. doi: 10.1111/j.1365-2605.2005.00621.x. Int J Androl. 2006. PMID: 16466550 Review.
-
Is testicular dysgenesis syndrome a genetic, endocrine, or environmental disease, or an unexplained reproductive disorder?Life Sci. 2018 Feb 1;194:120-129. doi: 10.1016/j.lfs.2017.11.039. Epub 2017 Nov 26. Life Sci. 2018. PMID: 29183799 Review.
-
Testicular dysgenesis syndrome and the development and occurrence of male reproductive disorders.Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):501-5. doi: 10.1016/j.taap.2005.01.058. Toxicol Appl Pharmacol. 2005. PMID: 16005920 Review.
-
Does a testicular dysgenesis syndrome exist?Hum Reprod. 2009 Sep;24(9):2053-60. doi: 10.1093/humrep/dep174. Epub 2009 May 14. Hum Reprod. 2009. PMID: 19443456 Review.
Cited by
-
A 10-Year Retrospective Study: Is Maternal Diabetes a Risk Factor for Associated Anomalies in Males With Cryptorchidism?Cureus. 2024 Sep 22;16(9):e69892. doi: 10.7759/cureus.69892. eCollection 2024 Sep. Cureus. 2024. PMID: 39439600 Free PMC article.
-
A pilot study of the association between genetic polymorphisms involved in estrogen signaling and infant male genital phenotypes.Asian J Androl. 2012 Sep;14(5):766-72. doi: 10.1038/aja.2012.27. Epub 2012 May 14. Asian J Androl. 2012. PMID: 22580635 Free PMC article.
-
Anti-Müllerian hormone: a potentially useful biomarker for the diagnosis of canine Sertoli cell tumours.BMC Vet Res. 2015 Jul 25;11:166. doi: 10.1186/s12917-015-0487-5. BMC Vet Res. 2015. PMID: 26209243 Free PMC article.
-
Competitive androgen receptor antagonism as a factor determining the predictability of cumulative antiandrogenic effects of widely used pesticides.Environ Health Perspect. 2012 Nov;120(11):1578-84. doi: 10.1289/ehp.1205391. Epub 2012 Sep 10. Environ Health Perspect. 2012. PMID: 23008280 Free PMC article.
-
Mono-(2-ethylhexyl) phthalate (MEHP) promotes invasion and migration of human testicular embryonal carcinoma cells.Biol Reprod. 2012 May 31;86(5):160, 1-10. doi: 10.1095/biolreprod.111.097295. Print 2012 May. Biol Reprod. 2012. PMID: 22321834 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
